SAN DIEGO, July 17, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company” or “BioAtla”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced an oral presentation at the upcoming 2025 European Society for Medical Oncology (ESMO) TAT Asia Meeting to be held in Hong Kong Sar, China from July 18–20, 2025. Oral Presentation Details: Title: First-in-human phase I study of a dual-Conditionally Active Biologic (CAB) EpCAM x CD3 bispecific T-cell engager (TCE), BA3182, in patients with treatment refractory metastatic adenocarcinoma Authors: Jennifer B.

CHANDLER, Ariz., July 17, 2025 (GLOBE NEWSWIRE) -- The growth of artificial intelligence (AI) and the electrification of everything are driving an ever-increasing demand for higher levels of power efficiency and reliability.

OREM, Utah, July 17, 2025 (GLOBE NEWSWIRE) -- SunPower (aka Complete Solaria, Inc.) (“SunPower” or the “Company”) (Nasdaq: SPWR), a solar technology, services, and installation company, today announced that it will release its quarterly investor report on Tuesday, July 22 prior to the market opening. A webcast will be hosted by CEO T.J.

LOS ANGELES, July 17, 2025 (GLOBE NEWSWIRE) -- LiveOne (Nasdaq: LVO), a creator-first music, entertainment and technology platform, today announced a strategic partnership with Arca, a leading institutional crypto-native asset management firm to co-manage its expanding cryptocurrency treasury portfolio. “By joining forces with Arca and leveraging our internal advisory team, we look forward to executing our multi-coin strategy aimed at generating high yield returns,” commented Robert Ellin, Chairman and CEO of LiveOne.

LEXINGTON, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (“TGF-ß”) family of proteins, today announced that the first patient was dosed in the Phase 3 RENEW clinical trial of elritercept in adults with transfusion-dependent anemia with very low, low, or intermediate risk myelodysplastic syndromes (“MDS”).

ST. LOUIS--(BUSINESS WIRE)--Cass Information Systems, Inc. (Nasdaq: CASS) (the Company or Cass) today reported its second quarter 2025 earnings as follows: ($ in thousands, except per share data) Quarter Ended June 30, 2025 Quarter Ended March 31, 2025 Quarter Ended June 30, 2024 Six-Months Ended June 30, 2025 Six-Months Ended June 30, 2024 Net income $ 8,855 $ 8,966 $ 4,484 $ 17,821 $ 11,636 Diluted earnings per share $ 0.66 $ 0.66 $ 0.32 $ 1.31 $ 0.84 Retur.

Conference call scheduled for the same day at 10:00 a.m. ET NEW YORK , July 17, 2025 /PRNewswire/ -- Newmark Group, Inc. (Nasdaq: NMRK) ("Newmark" or "the Company"), a leading commercial real estate advisor and service provider to large institutional investors, global corporations, and other owners and occupiers, today announced the details of its second quarter 2025 financial results press release and conference call.

SAN FRANCISCO , July 17, 2025 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises DocGo Inc. (NASDAQ: DCGO) investors that the firm is investigating potential legal claims relating to alleged false statements about the educational background of DocGo's former CEO and the company's business development efforts. Current shareholders are encouraged to contact us.

The Latest Addition to an Expansive Collection of Culinary Pairing Journeys Promises an Unmatched Gourmet Adventure at Sea Paired with World Famous Wines MIAMI , July 17, 2025 /PRNewswire/ -- Oceania Cruises®, the world's leading culinary- and destination-focused luxury cruise line, will unveil an exclusive Gérard Bertrand Food and Wine Pairing lunch, an immersive new signature experience designed to further elevate the brand's renowned food and wine offerings. Debuting aboard Oceania Allura™ during her highly anticipated inaugural voyage, which sets sail on July 18, 2025, the experience will also launch on Oceania Vista® in September, and will be available aboard …

SAN ANTONIO, July 17, 2025 (GLOBE NEWSWIRE) -- Rackspace Technology ® (NASDAQ: RXT), a leading end-to-end hybrid cloud and AI solutions company, today announced the availability of the Foundry for AI by Rackspace ("FAIR™") Model Context Protocol (“MCP”) Enterprise Accelerator on the AWS Marketplace in the new ‘AI Agents & Tools' category. Customers can now easily discover, purchase, and deploy AI-driven solutions, including Rackspace Technology's Agentic AI Professional Services through the AWS market, accelerating workflow development and enabling enterprise intelligence through AI agents.

COLUMBUS, Ohio, July 17, 2025 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building products, utilities, transportation and powersports industries across North America, today announces that it will release its second quarter fiscal 2025 results on Tuesday, August 5, 2025, before the market opens. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the internet the same day at 10:00am Eastern.

OKLAHOMA CITY , July 17, 2025 /PRNewswire/ -- Bank7 Corp. (NASDAQ: BSVN) ("the Company"), the parent company of Oklahoma City-based Bank7 (the "Bank"), today reported unaudited results for the quarter ended June 30, 2025. "We are thrilled to report another exceptional quarter.

SANTA MONICA, Calif., and VANCOUVER, BC, July 17, 2025 /PRNewswire/ -- Lionsgate (NYSE: LION) today announced it will release its financial results for the fiscal 2026 first quarter ended June 30, 2025 after market close on Thursday, August 7.

Directors John L. Davies and David J.

Hotel team members and guests can now enjoy six complimentary months of Grubhub+, unlocking $0 delivery fees on eligible orders and other exclusive perks when ordering food, groceries and everyday essentials PARSIPPANY, N.J. and CHICAGO , July 17, 2025 /PRNewswire/ -- Wyndham hotel team members and guests can now get everything from tacos to toothpaste delivered right to their doorstep—all with $0 delivery fees and other perks—thanks to a new partnership between Wyndham Hotels & Resorts and leading online and mobile food-ordering and delivery platform, Grubhub.

Blue Owl closes $850 million to launch next chapter of growth in Alternative Credit NEW YORK , July 17, 2025 /PRNewswire/ -- Blue Owl Capital Inc. (NYSE: OWL), a leading alternative asset manager, today announced the final close of the private offering of an alternative credit fund (the "Fund"), securing $850 million in capital commitments from a diverse client base across its global private wealth channel. The Fund seeks to provide current income, and to a lesser extent, capital appreciation through investments in alternative credit strategies with a focus on asset-based finance, such as financing solutions based on financial or …

PLANO, Texas , July 17, 2025 /PRNewswire/ -- Ribbon Communications Inc. (Nasdaq: RBBN), a global leader of real-time communications technology and IP optical networking solutions, has appointed Fahad Najam as Senior Vice President, Investor Relations and Corporate Strategy, effective immediately. This strategic hire reflects Ribbon's focus on accelerating its transformation and strengthening relationships with key stakeholders across the industry as it helps service providers, enterprises and critical infrastructure operators around the globe modernize and secure their networks and services.

New Drug Application supported by results from the Phase 2b SunRISe-1 study RARITAN, N.J. , July 17, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) granted Priority Review to the New Drug Application (NDA) filed for TAR-200, an intravesical gemcitabine releasing system, for the treatment of patients with Bacillus Calmette-Guérin (BCG)-unresponsive high-risk non-muscle invasive bladder cancer (HR-NMIBC) with carcinoma in situ (CIS), with or without papillary tumors.

Currently serving as Chief Administrative Officer, Woodrow brings a strong emphasis on people, culture and community to her expanded role BUFFALO, N.Y. , July 17, 2025 /PRNewswire/ -- M&T Bank (NYSE:MTB) has announced the appointment of Tracy S.

MENLO PARK, Calif. , July 17, 2025 /PRNewswire/ -- More than half of global executives (57%) are confident that AI will enhance customer experience, yet only 17% believe their organization is currently optimizing CX as effectively as they could be, as revealed by the latest survey in the VISION by Protiviti series, the "Protiviti-Oxford Global Executive Outlook on the Customer Experience (CX).